Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

TRDATRDA
19 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in ENTRADA THERAPEUTICS INC

BAKER BROS. ADVISORS LP holds 5.1M shares of TRDA (ENTRADA THERAPEUTICS INC), worth $37.3M as of 2026-Q2. TRDA represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$37.3M

Current Shares

5.1M

Total Value Change

-$43.2M

Total Shares Change

+368,311

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5.1M
0.0%
$37.3M0.2%$7.36
0
2026-Q1
Unchanged
5.1M
0.0%
$64M0.4%$11.85
0
2025-Q4
Increased
5.1M
+4.3%
$52.1M0.3%$10.09
37
2025-Q3
Unchanged
4.9M
0.0%
$28.2M0.2%$5.84
0
2025-Q2
Unchanged
4.9M
0.0%
$32.7M0.3%$6.91
0
2025-Q1
Unchanged
4.9M
0.0%
$44M0.5%$9.56
0
2024-Q4
Unchanged
4.9M
0.0%
$84.1M0.9%$17.37
0
2024-Q3
Unchanged
4.9M
0.0%
$77.8M0.8%$16.45
0
2024-Q2
Unchanged
4.9M
0.0%
$69.3M0.9%$14.25
0
2024-Q1
Unchanged
4.9M
0.0%
$68.9M0.9%$14.17
0
2023-Q4
Unchanged
4.9M
0.0%
$73.4M0.8%$15.09
0
2023-Q3
Unchanged
4.9M
0.0%
$76.9M0.4%$15.80
0
2023-Q2
Unchanged
4.9M
0.0%
$73.7M0.4%$15.06
0
2023-Q1
Unchanged
4.9M
0.0%
$70.6M0.4%$15.03
0
2022-Q4
Unchanged
4.9M
0.0%
$65.8M0.4%$13.52
0
2022-Q3
Unchanged
4.9M
0.0%
$76.7M0.5%$15.54
0
2022-Q2
Increased
4.9M
+3.4%
$59.3M0.3%$12.94
36
2022-Q1
Unchanged
4.7M
0.0%
$44.2M0.3%$9.55
0
2021-Q4
New
4.7M
-
$80.5M0.4%$18.37
49

Other major holders of TRDA: PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used